- Home
- BTAI vs SOPA Comparison
BTAI vs SOPA Comparison
Compare BTAI & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- SOPA
- Stock Information
- Founded
- BTAI 2017
- SOPA 2018
- Country
- BTAI United States
- SOPA Singapore
- Employees
- BTAI N/A
- SOPA N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- SOPA EDP Services
- Sector
- BTAI Health Care
- SOPA Technology
- Exchange
- BTAI Nasdaq
- SOPA Nasdaq
- Market Cap
- BTAI 7.2M
- SOPA 6.3M
- IPO Year
- BTAI 2018
- SOPA 2021
- Fundamental
- Price
- BTAI $1.88
- SOPA $0.83
- Analyst Decision
- BTAI Buy
- SOPA Buy
- Analyst Count
- BTAI 5
- SOPA 2
- Target Price
- BTAI $42.60
- SOPA $16.00
- AVG Volume (30 Days)
- BTAI 1.2M
- SOPA 87.0K
- Earning Date
- BTAI 03-27-2025
- SOPA 05-14-2025
- Dividend Yield
- BTAI N/A
- SOPA N/A
- EPS Growth
- BTAI N/A
- SOPA N/A
- EPS
- BTAI N/A
- SOPA N/A
- Revenue
- BTAI $2,266,000.00
- SOPA $6,906,240.00
- Revenue This Year
- BTAI $105.36
- SOPA $7.97
- Revenue Next Year
- BTAI $46.93
- SOPA $15.61
- P/E Ratio
- BTAI N/A
- SOPA N/A
- Revenue Growth
- BTAI 64.20
- SOPA N/A
- 52 Week Low
- BTAI $1.72
- SOPA $0.73
- 52 Week High
- BTAI $49.58
- SOPA $6.75
- Technical
- Relative Strength Index (RSI)
- BTAI 39.27
- SOPA 36.28
- Support Level
- BTAI $1.76
- SOPA $0.88
- Resistance Level
- BTAI $2.37
- SOPA $1.18
- Average True Range (ATR)
- BTAI 0.28
- SOPA 0.09
- MACD
- BTAI 0.03
- SOPA -0.00
- Stochastic Oscillator
- BTAI 16.95
- SOPA 2.61
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with visionary entrepreneurs, the company meets the growing demand for better services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food and grocery deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Merchant Point of Sale (merchant POS). The company generates the majority of its revenue from the Digital marketing segment.